NeuShen Therapeutics

Recent Finacing

Pre-Series A

Recent Raise

$20M

NeuShen Therapeutics is a biotechnology company operating in Shanghai and Boston that applies AAV-based gene therapy and small-molecule discovery platforms to develop treatments for central nervous system disorders.

Founded 2021

Shanghai, China

11-50

Private

neushen.com

Highlights

Focus Areas

Biotechnology

Medical

Recent Investors

Financials

$20M

Total Raised

1

Funding round

1

Investor

Team

Upgrade to view the team

See the team members at NeuShen Therapeutics.